Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines

Oncology Reports

Volumn 18, Issue 4, 2007, Pages 987-991

  Yoshizawa, Kunio ^a   Nozaki, Shinichi ^a   Kitahara, Hiroko ^a   Ohara, Teruhisa ^a   Kato, Koroku ^a   Kawashiri, Shuichi ^a   Yamamoto, Etsuhide ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Epithelial to mesenchymal transition; Multidrug resistance; Oral cancer

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTINEOPLASTIC AGENT; ATP7A PROTEIN, HUMAN; CATION TRANSPORT PROTEIN; CISPLATIN; COPPER; MESSENGER RNA; SLC31A1 PROTEIN, HUMAN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WILSON DISEASE PROTEIN;

ARTICLE; CELL CULTURE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG RESISTANCE; FEMALE; GENETICS; HUMAN; METABOLISM; MOUTH TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATASES; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CATION TRANSPORT PROTEINS; CISPLATIN; COPPER; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MOUTH NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 38449089214     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.4.987     Document Type: Article

References (27)

1. Miyashita H, Nitta Y, Mori S, et al: Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin. Oral Oncol 39: 157-162, 2003. (Pubitemid 36050921)
2. Fujii R, Mutoh M, Niwa K, et al: Active efflux system for cisplatin-resistant human KB cells. Jpn J Cancer Res 85: 426-433, 1994.
3. Hill BT and Price LA: Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvand chemotherapy prior to local therapy, despite of achieving an initial high clinical complete remission rate. Am J Clin Oncol 17: 1-5, 1994. (Pubitemid 24062724)
4. Samimi G, Safaei R, Katano K, et al: Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin and oxaliplatin in ovarian cancer cells. Clin Cancer Res 10: 4661-4669, 2004. (Pubitemid 38955516)
5. Beretta GL, Gatti L, Tinelli S, et al: Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells. Biochem Pharmacol 68: 283-291, 2004. (Pubitemid 38757697)
6. Nakagawa M, Nomura Y, Kohno K, et al: Reduction of drug accumulation in cisplatin-resistant variants of human prostate cancer PC-3 cell line. J Urol 150: 1970-1973, 1993. (Pubitemid 24350847)
7. Katano K, Kondo A, Safaei R, et al: Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res 62: 6559-6565, 2002. (Pubitemid 35364122)
8. Safaei R and Howell SB: Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit Rev Oncol Hematol 53: 13-23, 2005. (Pubitemid 39656107)
9. Song IS, Savarj N, Siddik ZH, et al: Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells. Mol Cancer Ther 3: 1543-1549, 2004. (Pubitemid 40136709)
10. Holzer AK, Samimi G, Katano K, et al: The copper influx transporter human copper transport protein 1 regulates the uptake cisplatin in human ovarian carcinoma cells. Mol Pharmacol 66: 817-823, 2004. (Pubitemid 39319453)
11. Katano K, Safaei R, Samimi G, Holzer A, Rochdi M and Howell SB: The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. Mol Pharmacol 64: 466-473, 2003. (Pubitemid 36910011)
12. Komatsu M, Sumizawa T, Mutoh M, et al: Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res 60: 1312-1316, 2000. (Pubitemid 30152000)
13. Nakayama K, Miyazaki K, Kanzaki A, Fukumoto M and Takebayashi Y: Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines. Oncol Rep 8: 1285-1287, 2001. (Pubitemid 33758731)
14. Kanzaki A, Toi M, Neamati N, et al: Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma. Jpn J Cancer Res 93: 70-77, 2002. (Pubitemid 34144714)
15. Yamamoto E, Kohama G, Sunakawa H, Iwai M and Hiratsuka H: Mode of invasion, bleomycin sensitivity and clinical course in squamous cell carcinoma of the oral cavity. Cancer 51: 2175-2180, 1983. (Pubitemid 13106840)
16. Nozaki S, Endo Y, Nakahara H, et al: Inhibition of invasion and metastasis in oral cancer by targeting urokinase-type plasminogen activator receptor. Oral Oncol 41: 971-977, 2005. (Pubitemid 41434063)
17. Kohno K, Uchiumi T, Niina I, et al: Transcription factors and drug resistance. Eur J Cancer 41: 2577-2586, 2005. (Pubitemid 41540632)
18. Nakayama K, Kanzaki A, Ogawa K, Miyazaki K, Neamati N and Takebayashi Y: Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP. Int J Cancer 101: 488-495, 2002.
19. Borst P, Evers R, Kool M and Wijnholds J: The multidrug resistance protein family. Biochim Biophys Acta 1461: 347-357, 1999.
20. Hinoshita E, Uchiumi T, Taguchi K, et al: Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin Cancer Res 6: 2401-2407, 2000. (Pubitemid 30399208)
21. Bentries-Alj M, Barbu V, Fillet M, et al: Inhibition of NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 22: 90-97, 2003. (Pubitemid 36152887)
22. Mabuchi S, Ohmichi M, Nishio Y, et al: Inhibition of NF-κB increases the efficacy of cisplatin in vitro and in vivo ovarian cancer models. J Biol Chem 279: 23477-23485, 2004. (Pubitemid 38685659)
23. Huber MA, Azoitei N, Baumann B, et al: NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114: 569-581, 2004. (Pubitemid 39572107)
24. Huber MA, Beug H and Wirth T: Epithelial-mesenchymal transition: NF-κB takes center stage. Cell Cycle 3: 1477-1480, 2004. (Pubitemid 40521393)
25. Vincenti MP, Coon CL and Brinckerhoof CE: Nuclear factor κB/p50 activates an element in the distal matrix metalloproteinase 1 promptor in interleukin-1β-stimulated synovial fibroblasts. Arthritis Rheum 41: 1987-1994, 1998. (Pubitemid 28506689)
26. Yang AD, Fan F, Camp ER, et al: Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 12: 4147-4153, 2006.
27. Taki M, Kamata N, Yokoyama K, Fujimoto R, Tsutsumi S and Nagayama M: Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Cancer Sci 94: 593-597, 2003. (Pubitemid 36975013)